IL102610A - Process for the preparation of demethylepipodoph- yllotoxin -b-d- glucosides and certain novel b-d- glucosides - Google Patents

Process for the preparation of demethylepipodoph- yllotoxin -b-d- glucosides and certain novel b-d- glucosides

Info

Publication number
IL102610A
IL102610A IL102610A IL10261092A IL102610A IL 102610 A IL102610 A IL 102610A IL 102610 A IL102610 A IL 102610A IL 10261092 A IL10261092 A IL 10261092A IL 102610 A IL102610 A IL 102610A
Authority
IL
Israel
Prior art keywords
glucosides
group
yllotoxin
demethylepipodoph
preparation
Prior art date
Application number
IL102610A
Other languages
English (en)
Original Assignee
Sicor Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11360401&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL102610(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sicor Spa filed Critical Sicor Spa
Publication of IL102610A publication Critical patent/IL102610A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
IL102610A 1991-07-23 1992-07-22 Process for the preparation of demethylepipodoph- yllotoxin -b-d- glucosides and certain novel b-d- glucosides IL102610A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI912025A IT1250692B (it) 1991-07-23 1991-07-23 Procedimento per la preparazione di demetilepipodofillotossina- beta-d-glucosidi.

Publications (1)

Publication Number Publication Date
IL102610A true IL102610A (en) 1997-03-18

Family

ID=11360401

Family Applications (1)

Application Number Title Priority Date Filing Date
IL102610A IL102610A (en) 1991-07-23 1992-07-22 Process for the preparation of demethylepipodoph- yllotoxin -b-d- glucosides and certain novel b-d- glucosides

Country Status (16)

Country Link
US (1) US5688925A (el)
EP (1) EP0595888B1 (el)
JP (1) JP3231765B2 (el)
AT (1) ATE159026T1 (el)
AU (1) AU666322B2 (el)
CA (1) CA2113894C (el)
DE (1) DE69222643T2 (el)
DK (1) DK0595888T3 (el)
ES (1) ES2107546T3 (el)
FI (1) FI110782B (el)
GR (1) GR3025729T3 (el)
IL (1) IL102610A (el)
IT (1) IT1250692B (el)
MX (1) MX9204334A (el)
WO (1) WO1993002094A1 (el)
ZA (1) ZA925515B (el)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2191733T3 (es) * 1995-12-04 2003-09-16 Nippon Kayaku Kk Procedimiento para producir etoposido.
ES2206917T3 (es) * 1997-06-02 2004-05-16 Bristol-Myers Squibb Company Procedimiento de preparacion de etoposido.
AU5612399A (en) 1998-09-10 2000-04-03 Phytogen Life Sciences Inc. Synthetic method for the preparation of the antineoplastic agent etoposide
FR2791681B1 (fr) * 1999-03-29 2001-06-22 Pf Medicament Nouveau procede de preparation de l'etoposide
GB0019124D0 (en) * 2000-08-03 2000-09-27 Pfizer Novel process
US20080161251A1 (en) 2005-01-21 2008-07-03 Astex Therapeutics Limited Pharmaceutical Compounds
US8916552B2 (en) 2006-10-12 2014-12-23 Astex Therapeutics Limited Pharmaceutical combinations
EP2073807A1 (en) 2006-10-12 2009-07-01 Astex Therapeutics Limited Pharmaceutical combinations
KR102090740B1 (ko) 2011-10-03 2020-03-18 엠엑스 아쥬바크 에이비 암 치료 및 식품 관련 화합물을 포함하는 의학 분야에서 양친매성 또는 소수성 분자를 위한 나노입자, 제조 방법 및 담체로의 용도
AR095962A1 (es) 2013-04-01 2015-11-25 Moreinx Ab Nanopartículas, compuestas de esterol y saponina de quillaja saponaria molina, proceso para preparación y uso de las mismas como portadores para moléculas anfipáticas o hidrófobas en el campo de la medicina incluyendo tratamiento de cáncer y compuestos relacionados con alimentos
EP3616688A1 (en) 2018-08-27 2020-03-04 Centre National de la Recherche Scientifique - CNRS Preparation of nanosuspension comprising nanocrystals of active pharmaceutical ingredients with little or no stabilizing agents
EP3669890A1 (en) 2018-12-18 2020-06-24 Croda International PLC Filamentous nanoparticles having vaccine adjuvant effect
CN113121618A (zh) * 2021-04-07 2021-07-16 梯尔希(南京)药物研发有限公司 两种依托泊苷杂质的制备方法
CN115197281B (zh) * 2021-04-09 2024-06-14 四川汇宇制药股份有限公司 依托泊苷中间体的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3374317D1 (en) * 1982-11-26 1987-12-10 Nippon Kayaku Kk Process for producing 4'-demethyl-epipodophyllotoxin-beta-d-ethylidene-glucoside and acyl-derivative thereof
JPS60246393A (ja) * 1984-05-22 1985-12-06 Nippon Kayaku Co Ltd エトポシドの新規製造法
IL77334A (en) * 1985-12-16 1991-04-15 Univ Bar Ilan Synthesis of 9-epipodophyllotoxin glucoside derivatives and some novel intermediates therefor
DK39886D0 (da) * 1986-01-27 1986-01-27 Hans Goeran Magnusson Hydroxybeskyttelsesgrupper
US4904768A (en) * 1987-08-04 1990-02-27 Bristol-Myers Company Epipodophyllotoxin glucoside 4'-phosphate derivatives
US4965348A (en) * 1989-05-19 1990-10-23 Bristol-Myers Company Dimeric epipodophyllotoxin glucoside derivatives
US5036055A (en) * 1989-06-07 1991-07-30 Bristol-Myers Company Acylated derivatives of etoposide
DE3935016A1 (de) * 1989-10-20 1991-04-25 Behringwerke Ag Glycosyl-etoposid-prodrugs, verfahren zu ihrer herstellung und ihre anwendung in kombination mit funktionalisiertem tumorspezifischen enzym-konjugaten
FR2658824B1 (fr) * 1990-02-27 1992-07-03 Pf Medicament Tris acetyl-2",3",4' ethylidene-4",6" beta-d-glucopyranosides, leur preparation et leur utilisation pour la preparation d'ethylidene beta-d-glucopyranoside de demethyl-4' epipodophyllotoxine.
US5081234A (en) * 1990-04-30 1992-01-14 Bristol-Myers Squibb Co. 4'-demethylepipodophyllotoxin glycosides
CN1025918C (zh) * 1990-06-07 1994-09-14 国家医药管理局上海医药工业研究院 抗肿瘤药表鬼臼毒吡喃糖甙的合成新工艺

Also Published As

Publication number Publication date
US5688925A (en) 1997-11-18
WO1993002094A1 (en) 1993-02-04
ITMI912025A0 (it) 1991-07-23
CA2113894A1 (en) 1993-02-04
JP3231765B2 (ja) 2001-11-26
DE69222643T2 (de) 1998-02-05
IT1250692B (it) 1995-04-21
FI940280A0 (fi) 1994-01-20
DE69222643D1 (de) 1997-11-13
JPH06509334A (ja) 1994-10-20
ATE159026T1 (de) 1997-10-15
MX9204334A (es) 1993-02-01
EP0595888B1 (en) 1997-10-08
ITMI912025A1 (it) 1993-01-24
EP0595888A1 (en) 1994-05-11
FI940280A (fi) 1994-01-20
FI110782B (fi) 2003-03-31
GR3025729T3 (en) 1998-03-31
AU2326592A (en) 1993-02-23
ZA925515B (en) 1993-04-28
ES2107546T3 (es) 1997-12-01
AU666322B2 (en) 1996-02-08
DK0595888T3 (da) 1998-05-18
CA2113894C (en) 2003-12-16

Similar Documents

Publication Publication Date Title
IL102610A (en) Process for the preparation of demethylepipodoph- yllotoxin -b-d- glucosides and certain novel b-d- glucosides
JPS57131791A (en) Benzodiazepine derivative and its preparation
ZA835143B (en) Intermediates for the preparation of omeprazole
HUT60719A (en) Process for producing 3-aminopiperidine derivatives
ZA947182B (en) Process for the preparation of 3-arylbenzofuranones
PT79839B (en) Process for the preparation of 6,6-ethylene-15,16-methylene-3-oxi-17alpha-pregn-4-ene-21,17-carbolactones and pharmaceutical compositions therewith
ZA858418B (en) 5-alkyl-1-phenyl-2-piperazinoalkylpyrazoline-3-one compounds and methods for the preparation thereof,intermediates for use in the preparation of said compounds and medicaments containing said compounds
ES8302733A1 (es) Un procedimiento para preparar nuevos derivados de antraci- clina
CS387391A3 (en) Phenylalkylaminoalkyl compounds, process of their preparation andmedicaments comprising said compounds
IE831004L (en) Long-acting theophylline in medicinal form
ES8403911A1 (es) Procedimiento de preparacion de mononitratos de 1.4,3.6- dianhidro-hexito sustituidos en 2-0 y 5-0
ES8609331A1 (es) Un procedimiento para preparar 2-bencil-7,7-dimetil-6,8- dioxa-2-espiro(3,5)nonano
HUT65533A (en) Process for producing 2-amino-pyrimidine-4-carboxamide derivatives and pharmaceutical preparations containing them
DE3564426D1 (en) Polyprenyl compound, process of producing it and pharmaceutical use
JPS56122357A (en) 7*88amino*hydroxyy11phenyll2*3*4*55tetrahydroo 1hh33bezazepines* their manufacture and medicinal composition containing them
IE44403L (en) CIS-4a-PHENYL-ISOQUINOLINES
DE3880088D1 (de) Ethylierte avermectine.
JPS5653654A (en) Preparation of novel aniline derivative
ES2004215A6 (es) Procedimiento para preparar quinazolinas tetraciclicas
JPS5772996A (en) Novel oligomannoside and its preparation
PT75251B (en) Process for the preparation of 6-<3,6-dihydro-1(2h)-pyridyl>-pyrimidine-3-oxides
JPS53127451A (en) 1-alkoxytricyclo (4.3.1.1. u2,5 ) their preparation, and perfume compositions containing the same
EG15868A (en) Flurophenoxybenzyl esters,their preparation and use as pesticides
JPS53101336A (en) Cyclooentenedione derivatives, process for their preparation and fungicides for agirculture and horiticulture containing the same
JPS53137971A (en) Bis(iminodiacetaldehyde) derivatives and process for their preparation

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees